Page 186 - PROGRAMME2018

WEDNESDAY, 4 JULY 2018
SELECTED ORAL COMMUNICATIONS
14:00 - 15:15 Room 116
Session 77: Female fertility from genomic studies to novel therapies
Chairman: A. Salumets (Estonia) Chairman: E. Labarta Demur (Spain)
14:00 O-300
A comprehensive two-centre RNA-seq study reveals changes in endometrial and blood miRNome at mid-secretory phase in fertile women and in patients with recurrent implantation failure
A. Velthut-Meikas1, S. Altmäe2, K. Rekker3, M. Suhorutshenko3, M. Peters3, J.F. Martinez-Blanch4, F.M. Codoñer5, F. Vilella5, C. Simón6, A. Salumets3
1Tallinn University of Technology, Department of Chemistry and Biotechnology, Tallinn, Estonia 2University of Granada, Department of Biochemistry and Molecular Biology, Granada, Spain 3Competence Centre on Health Technologies, Competence Centre on Health Technologies, Tartu, Estonia 4Lifesequencing SL, Lifesequencing SL, Valencia, Spain
5Igenomix Foundation/INCLIVA, Igenomix Foundation/INCLIVA, Valencia, Spain 6Valencia University, Department of Obstetrics and Gynecology, Valencia, Spain
Sirolimus as a new drug for treatment of RIF patients with elevated Th17/Treg Ratio: a randomized, double-blind, phase II clinical trial
M. Ahmadi1, S. Danaii2, K. Berjis3, M. Nouri4, M. Yousefi5
1Stem Cell and Regenerative Medicine Institute- Tabriz University of Medical Sciences- Tabriz- Iran, Department of Immunology, Tabriz, Iran
2Gynecology Department- Eastern Azerbaijan ACECR ART center- Eastern Azerbaijan branch of ACECR- Tabriz- Iran., Gynecology Department, Tabriz, Iran
3Academic Center for Education- Culture and Research- ACECR- Qom Branch- Qom- Iran, Gynecology Department, Qom, Iran
4Stem Cell and Regenerative Medicine Institute- Tabriz University of Medical Sciences- Tabriz- Iran, Department of Biochemistry, Tabriz, Iran
5Department of Immunology- School of Medicine- Tabriz University of Medical Sciences- Tabriz- Iran, Department of Immunology, Tabriz, Iran
14:15 O-301
186